Adipotide (FTPP) – Targeted Pro-Apoptotic Peptidomimetic for Metabolic Research Adipotide is a synthetic peptidomimetic designed to selectively target and disrupt blood vessels supplying white adipose tissue. Engineered for high-specificity metabolic and fat tissue signaling research, offering premium $\ge 98\%$ purity verified by HPLC.

Targeted Fat Metabolism & Lean Body Composition (Advanced Anti-Lipogenic Peptide) AOD-9604 is a modified fragment of human growth hormone (hGH 177-191) designed to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation) without impacting blood sugar levels or tissue growth. An optimal choice for precision metabolic research and body composition protocols.

Innovative Amylin Analogue for Dual Appetite & Weight Management Cagrilintide is a novel, long-acting amylin receptor agonist designed to work independently or synergistically with GLP-1 therapies. It targets brain satiety centers to slow gastric emptying, significantly reduce cravings, and support effective, long-term body composition optimization.

Targeted Growth Hormone Release & Recovery Optimization CJC-1295 (without DAC), also known as Modified GRF (1-29), is a potent growth hormone-releasing hormone (GHRH) analog designed for precise, pulsatile stimulation of natural GH production. Perfect for targeted recovery, lean muscle support, and metabolic research.

Premium Delta Sleep-Inducing Peptide (DSIP) Restorative Sleep & Stress Resiliency Support Formulated to support deep, restorative delta-wave sleep, stress response modulation, and baseline hormonal recovery. Engineered for high purity and consistency in cell and metabolic research.

Targeted Senolytic & Anti-Aging Research Peptide FOXO4-DRI is a pioneer senolytic peptide designed to selectively disrupt the FOXO4-p53 interaction. By inducing apoptosis in senescent (“zombie”) cells while sparing healthy tissue, it supports cellular rejuvenation, tissue regeneration, and longevity research.